$Vroom, Inc.(VRM)$During trading today, shares of VRM stock have shot up by over 35% at midday which is quite substantial. This is also a major bullish turnaround from its past month performance which is down by around 32%. And, in the past six months, shares of VRM stock have fallen by around 90%. While many penny stocks climb with little to no news, VRM made an exciting announcement that is causing its sizable uptick right now.At EOD on May 9th, the company reported its Q1 2022 financials, which exceeded guidance on all key metrics. In addition, it announced a business realignment plan. Looking at the report, we see that its e-commerce units sold increased 26% YoY, with its e-commerce revenue increasing by over 60% YoY. And, the company managed t

$Clover Health Corp(CLOV)$Signals & ForecastThe Clover Health Investments stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.65 and $2.41. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 21, 2022, and

$HIVE Blockchain Technologies Ltd.(HIVE)$reverse stock splits are an admission of a struggling firm — a huge red flag, “Investors are well served to sell their holdings of firms announcing reverse stock splits. Investors not holding securities of those firms should refrain from buying them.”Just as with a stock split, there’s no change to the market capitalization of a company, nor is there a change to each investor’s stake. However, they can still be a sign of trouble. Companies may go through reverse stock splits to avoid being delisted from a stock exchange if they’re nearing the minimum share price allowed on that exchange. They also might do a reverse stock split to improve the company’s public image or draw attention from high-profile i

$Catalyst Biosciences(CBIO)$ Buy Candidate Catalyst Biosciences, Inc. (CBIO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. Therefore, the Zacks rating upgrade for Catalyst Biosciences, Inc. basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to

$Clover Health Corp(CLOV)$Clover Health Investments grew its revenue by 188% over the last year. That's a strong result which is better than most other loss making companies. Meanwhile, the share price slid 70%. This could mean hype has come out of the stock because the bottom line is concerning investors. We'd definitely consider it a positive if the company is trending towards profitability. If you can see that happening, then perhaps consider adding this stock to your watchlist.Credit: Nasdaq

$Tiger Brokers(TIGR)$Tiger Brokers Australia’s Chief Strategy Officer Michael McCarthy says the Australian market has “fared better than most” as share markets globally continue to fall.“In Europe and the US, we’ve seen weekly drops for every one of the last five weeks,” he told Sky News host Ross Greenwood.“So while we’ve dropped eight per cent in just four sessions, we’re still a lot better off than many investors around the globe.”

$Vroom, Inc.(VRM)$Vroom (VRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.

$Credit Suisse Group AG(CS)$ It's gonna be safe. Matter of time it will hit the moon. Credit Suisse tapped an emergency lifeline worth 50 billion Swiss franc ($54 billion) from its central bank on Thursday. The Swiss rescue calmed markets and emboldened the ECB to raise interest rates by another half-a-percentage point on Thursday, confounding traders' bets and sticking to its inflation-fighting efforts.

$Lufax(LU)$ Strong Buy Candidate The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 72.72% during the next 3 months and, with a 90% probability hold a price between $4.36 and $5.84 at the end of this 3-month period. Should take note that LU currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. Credit: StockInvest

$HIVE Blockchain Technologies Ltd.(HIVE)$KEY TAKEAWAYSA reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares.A reverse stock split does not directly impact a company's value (only its stock price).It can signal a company in distress since it raises the value of otherwise low-priced shares.Remaining relevant and avoiding being delisted are the most common reasons for corporations to pursue this strategy.

$Imperial Petroleum Inc(IMPP)$ATHENS, Greece, May 17, 2022 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (Nasdaq: IMPP) (the “Company”) announced today the pricing of an underwritten public offering of 72,727,272 units at a price of $0.55 per unit. Each unit consists of one share of common stock and one Class C warrant to purchase one share of common stock, and will immediately separate upon issuance. The gross proceeds of the offering to the Company, before underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $40 million.The Company intends to use the net proceeds of the offering for capital expenditures, including acquisitions of additional vessels which we have not yet identified, which may incl

$Tiger Brokers(TIGR)$Reported its unaudited financial results for the first quarter ended March 31, 2022. Total revenue in the first quarter was US$52.6 million. Non-GAAP net loss was US$1.9 million.At the end of the first quarter, customer accounts totaled 1.9 million, and the number of customers with deposits increased to 703,500, an increase of 87.1% from the same quarter last year. The company’s net asset inflow was US$3.5 billion this quarter.

$Lufax(LU)$ No longer high divident payout quarterly  Disappointment  * NET INTEREST INCOME INCREASED BY 3.2% TO RMB4,369 MILLION (US$633 MILLION) IN Q4 OF 2022 * LUFAX HOLDING - UNDER REVISED DIVIDEND POLICY, CO WILL DECLARE RECURRING CASH DIVIDEND SEMI-ANNUALLY * LUFAX HOLDING - AMOUNT OF SEMI-ANNUAL DIVIDEND DISTRIBUTIONS FOR EACH YEAR IS EQUIVALENT TO APPROX 20% TO 40% OF CO'S NET PROFIT IN SUCH FISCAL YEAR

$Lufax(LU)$ Downgrade to Sell Candidate.  The Lufax Holding Ltd stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $3.11. On a fall, the stock will find some support from the long-term average at approximately $2.47. A sell signal was issued from a pivot top point on Wednesday, February 01, 2023, and so far it has fallen -9.42%. Further fall is indicated until a new bottom pivot has been found. Volume fell toget

$ProQR Therapeutics NV(PRQR)$The consensus EPS estimate for the current year has increased 14.6% over the last 30 days. This means that the Wall Street analysts covering PRQR are majorly in agreement about the company's potential to report better earnings than what they predicted earlier.If this is not enough, you should note that PRQR currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Moreover, the Zacks Rank has proven to be an excellent timing indicator,

$DiDi Global Inc.(DIDI)$If DiDi delists, there are essentially three possible outcomes for investors: a share buyback, share transfer, or share limbo.In a buyback scenario, the Chinese company could purchase its shares back from investors at a price agreed upon by shareholders—effectively going private. If the company wishes to go public again, it would do so in a separate listing in the likes of Hong Kong.In a share transfer scenario, investors would swap their ADR for the Chinese company’s foreign stock. In the case of DiDi, which doesn’t have a secondary listing, would need to first launch a listing—in Hong Kong or Shanghai, for instance— to establish both a home for its foreign stock and mechanism for the transfer of ADRs.If DiDi doesn’t buy b

$DiDi Global Inc.(DIDI)$DiDi Global shares jumped more than 7% in premarket trading after it was reported that carmaker China FAW Group is considering taking a stake in the firm.Shares are down more than 60% this year.FAW, one of China’s biggest automotive firms, has reached out to DiDi executives about becoming a major shareholder and help the company solve issues related to data security, Bloomberg reported Friday. Discussions may not lead to any transaction.

$Vroom, Inc.(VRM)$From my last 2-3 weeks post, my analysis works. Advice to buy on pre market before market opens. Vroom (NASDAQ:VRM) is scheduled to announce Q2 earnings results on Monday, August 8th, after market close.The consensus EPS Estimate is -$0.75 (-56.3% Y/Y) and the consensus Revenue Estimate is $543.88M (-28.6% Y/Y).Over the last 1 year, VRM has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.Over the last 3 months, EPS estimates have seen 6 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 10 downward.

$Evolution(EPM)$ On September 12, 2023, Evolution Petroleum Corporation, Inc. (NYSE:EPM) announced its fourth-quarter earnings, falling short of the analyst consensus estimate. The company reported zero cents per share, marking a significant decline of 99.77% compared to the 44 cents per share earned during the same period in the previous year. Additionally, Evolution Petroleum’s quarterly sales amounted to $18.17 million, which also missed the analyst consensus estimate of $21.64 million. This represented a decrease of 56.75% in comparison to the $42.02 million in sales generated during the same period last year.

$HIVE Blockchain Technologies Ltd.(HIVE)$HIVE Blockchain Technologies is a cryptocurrency miner which owns green energy powered data center facilities in Canada, Sweden and Iceland.In July, HIVE Blockchain Technologies announced it had record annual revenue for the year ended Mar 31, 2022. Revenue was $211 million with earnings of $79 million, or $0.90 per share.But shares of HIVE Blockchain Technologies have fallen 62% year-to-date even while it’s reporting record revenue.It’s extremely cheap, with a forward P/E of just 1.4 and analysts are bullish on fiscal 2023, with earnings expected to rise 283%.Should value investors take a chance on small cap HIVE Blockchain Technologies or is the P/E telling you to be cautious?Credit: YahooNews